Pfizer AH: 13% revenue increase
Pharmaceutical company Pfizer's animal health division
posted third-quarter 2007 revenues $636 million, a 13% increase in comparison to
$562 million in the same period last year.
For the first nine months of 2007, revenues increased 12% to $1.9 billion
compared to $1.7 billion in the same period last year.
The increase in both periods is largely attributed to strong product
performance in the companion animal and international livestock businesses; the
acquisition of Embrex, a company with a unique vaccine delivery system that
vaccinates chicks while inside their eggs; and the favorable impact of foreign
The results were made public in a company press release.
Pfizer as a total posted third-quarter 2007 revenues of $12.0 billion, a 2%
decline from the same period last year.
To comment, login here
Or register to be able to comment.